CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Analysis of 13C6 glucose-labelled samples revealed that for all metabolites labelled from glucose, the fraction of labelling was consistently higher in CML CD34+ cells (Fig. 1g and Supplementary Fig. S1E)12.